How Technology Is Changing The Game For Retail Stock Traders
With the rapid evolution of technology in the past few decades, we have seen a complete revamp of many industries, and stock trading is no…
Rags Or Riches: Understanding The Best AI Bets
There has been a ton of press on artificial intelligence (AI) recently. But in all the news articles I’ve read and TV snippets I’ve seen,…
7 Pharma Stocks To Buy For Groundbreaking Treatments And Robust Revenue Growth
Pharma stocks can be a great way to add profits to your investment account. Companies that make lifesaving medications or develop treatments to ease symptoms…
Warren Buffett’s Biggest Bets: The 7 Stocks Dominating His Portfolio
Since taking over the reins of Berkshire Hathaway (NYSE:BRK-A, NYSE:BRK-B) as CEO in 1965, Warren Buffett has overseen compounded gains of 20% a year. That’s…
7 Stocks Hedge Funds Are Loading Up On
Emulating the moves of hedge fund stock pickers, and some of the most successful hedge funds can produce sizable profits for retail investors. In fact,…
7 Up-And-Coming AI Stocks To Put On Your Must-Buy List
Nvidia (NASDAQ:NVDA) proved the artificial intelligence (AI) boom is here to stay. Revenue jumped by 101% year-over-year, as net income soared by 843% year-over-year. While…
3 Up-and-Coming IPOs To Put On Your Must-Buy List
Initial public offering (IPO) is the stock issuance process onto the public market. All of these companies are striving to be deemed up-and-coming IPOs. An…
The Power Of Dividend Growth: 3 Stocks That Outshine The Rest
Top dividend stocks offer dependable long-term income, acting as an effective hedge against inflation. They outperform non-dividend stocks, with S&P 500 dividend growth stocks providing…
Timeless Titans: 3 Blue-Chip Stocks Destined For 100% Gains By 2024
From early 2022 highs of close to $400, Tesla (NASDAQ:TSLA) stock plunged to lows of $102 at the beginning of the year. However, the stock…
Untapped Potential: 3 Stocks Tackling The Toughest Rare Diseases
Rare disease stocks have a difficult task. The rarer a disease is, the less public research goes into studying it. And that in turn makes…